NCT01800487View on ClinicalTrials.gov

The Efficacy of Silymarin on the Prevention of Hepatotoxicity From Antituberculosis Drugs

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

July 31, 2013

Conditions
Tuberculosis
Interventions
DRUG

silymarin

140 mg three times a day for 4 weeks

DRUG

Placebo

Placebo (silymarin) 1 tab three times a day for 4 weeks

Trial Locations (1)

10400

Gastroenterology and Hepatology, Ramathibodi hospital, Bangkok

All Listed Sponsors
lead

Ramathibodi Hospital

OTHER

NCT01800487 - The Efficacy of Silymarin on the Prevention of Hepatotoxicity From Antituberculosis Drugs | Biotech Hunter | Biotech Hunter